Tag: cancer genetics

January 29, 2019

Cancer Genetics Announces Pricing of $3.5 Million Public Offering of Common Stock

Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today...
December 17, 2018

Cancer Genetics Terminates Proposed Merger with NovellusDx

Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today...
October 18, 2018

Cancer Genetics and Genecast Partner on Gene Test

Cancer Genetics announced on Thursday that it has partnered with China-based Genecast Biotechnology to market, distribute and sell the Tissue...
October 18, 2018

Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin Test in China

Cancer Genetics (Nasdaq:CGIX) a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced...
October 3, 2018

VIDEO — Life Science Update September 2018

With September officially behind us, the Investing News Network is taking a look back at some of the biggest news...
September 18, 2018

Cancer Genetics Merges with NovellusDx

Two companies with similar oncology goals, Cancer Genetics and NovellusDx, have signed a definitive merger agreement, announced Tuesday.
September 18, 2018

Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge

Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, and...